klow-con and xeloda (Capecitabine): Side Effects, Uses, Dosage, Interactions, Warnings Understanding DPD Deficiency in Chemotherapy
Description
, Rath, N
The -arrestins show high affinity for receptors that are both phosphorylated and activated, but are still able to bind non-phosphorylated receptors with a lower affinity
We have that technology
22 ChenY.-Y.LoH.-F.WangT.-F.LinM.-G.LinL.-L.ChiM.-C
